{"groups":[{"description":"Participants were mobilized with granulocyte colony-stimulating factor (G-CSF) 10 µg/kg/day for 4 days. Plerixafor 240 µg/kg was given the evening of day 4 and G-CSF given the next morning followed by apheresis. Evening doses of plerixafor and morning doses of G-CSF followed by apheresis continued for up to a maximum of 7 aphereses or until ≥ 2\\*10\\^6 CD34+ cells/kg were collected.","id":"FG000","title":"G-CSF Plus Plerixafor"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"8"}],"type":"Failed to mobilize - no transplant"},{"reasons":[{"groupId":"FG000","numSubjects":"5"}],"type":"Did not go on to transplant"},{"reasons":[{"groupId":"FG000","numSubjects":"3"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"16"}],"type":"Death"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"100"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"100"}],"type":"Number of Participants Treated"},{"achievements":[{"comment":"7 participants had two transplants","groupId":"FG000","numSubjects":"87"}],"type":"Number of Participants Transplanted"},{"achievements":[{"groupId":"FG000","numSubjects":"68"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"32"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"Four participants were enrolled in the study but never received plerixafor treatment so are not included below. Reasons for not receiving plerixafor included disease progression (2), infection (1) and insurance issues (1)."}